CytoMed Therapeutics Ltd (GDTC) Insider Trading Disclosures
CytoMed Therapeutics Ltd (GDTC) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GDTC
CIK: 1873093
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: U0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WWC, P.C.
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerHing Yan Teo
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-10-16 | — | SCHEDULE 13D/A Filing | 0001493152-26-047321 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-10-13 | — | SCHEDULE 13D/A Filing | 0001493152-26-046685 | View SEC Doc Filr Page |
| 6-K | 2026-10-13 | 2026-10-09 | 6-K | 0001493152-26-046630 | View SEC Doc Filr Page |
| 6-K | 2026-09-30 | 2026-06-30 | 6-K | 0001493152-26-045045 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001477932-26-004854 | View SEC Doc Filr Page |
| 4/A | 2026-07-24 | 2026-07-14 | 4/A | 0001493152-26-034654 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-24 | — | SCHEDULE 13D/A Filing | 0001493152-26-034520 | View SEC Doc Filr Page |
| 4 | 2026-07-24 | 2026-07-14 | 4 | 0001493152-26-034516 | View SEC Doc Filr Page |
| 6-K | 2026-06-23 | 2026-06-23 | 6-K | 0001493152-26-029736 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-08 | 4 | 0001493152-26-028589 | View SEC Doc Filr Page |
| 6-K | 2026-06-03 | 2026-06-03 | 6-K | 0001493152-26-027044 | View SEC Doc Filr Page |
| 3 | 2026-05-26 | 2026-03-18 | 3 | 0001493152-26-025179 | View SEC Doc Filr Page |
| 3 | 2026-05-15 | 2026-03-18 | 3 | 0001493152-26-023405 | View SEC Doc Filr Page |
| 3 | 2026-05-15 | 2026-03-18 | 3 | 0001493152-26-023404 | View SEC Doc Filr Page |
| 3 | 2026-05-15 | 2026-03-18 | 3 | 0001493152-26-023401 | View SEC Doc Filr Page |
| 3 | 2026-05-15 | 2026-03-18 | 3 | 0001493152-26-023400 | View SEC Doc Filr Page |
| 3 | 2026-05-15 | 2026-03-18 | 3 | 0001493152-26-023399 | View SEC Doc Filr Page |
| 6-K | 2026-05-15 | 2026-05-15 | 6-K | 0001493152-26-023342 | View SEC Doc Filr Page |
| 144 | 2026-05-13 | — | 144 Filing | 0001477932-26-003023 | View SEC Doc Filr Page |
| 6-K | 2026-05-11 | 2026-05-11 | 6-K | 0001493152-26-022134 | View SEC Doc Filr Page |
| 6-K | 2026-04-14 | 2026-04-14 | 6-K | 0001493152-26-016552 | View SEC Doc Filr Page |
| 6-K | 2026-03-31 | 2026-03-31 | 6-K | 0001493152-26-013882 | View SEC Doc Filr Page |
| 20-F | 2026-03-31 | 2025-12-31 | 20-F | 0001493152-26-013813 | View SEC Doc Filr Page |
| 144 | 2026-02-12 | — | 144 Filing | 0001477932-26-000766 | View SEC Doc Filr Page |
| 6-K | 2026-01-28 | 2026-01-28 | 6-K | 0001493152-26-003920 | View SEC Doc Filr Page |